{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05406362",
            "orgStudyIdInfo": {
                "id": "VAD044C002"
            },
            "organization": {
                "fullName": "Vaderis Therapeutics AG",
                "class": "INDUSTRY"
            },
            "briefTitle": "Assess Safety and Efficacy of VAD044 in HHT Patients",
            "officialTitle": "A Randomised, Placebo Controlled, Double Blind, Multicentre Proof of Concept Study to Assess the Safety and Efficacy of Two Doses of VAD044 in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "assess-safety-and-efficacy-of-in-hht-patients"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2022-07-18",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-03",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2022-05-10",
            "studyFirstSubmitQcDate": "2022-06-01",
            "studyFirstPostDateStruct": {
                "date": "2022-06-06",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-05-03",
            "lastUpdatePostDateStruct": {
                "date": "2023-05-06",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "Vaderis Therapeutics AG",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "The purpose of this Phase 1b proof of concept study, randomised, placebo controlled, double blind, multicentre study is to asssess safety and efficacy of 2 doses of VAD044 in adult HHT patients",
            "detailedDescription": "After being informed about the study and the potential risks, all patients giving written informed consent will undergo a two months screening and observation period to determine eligibility for study entry. At Day 0, patients who meet the eligibility requirements will be randomized in a double-blind manner (participant and investigator) in a 1:1:1 ratio to 30mg VAD044 (once daily), 40 mg (once daily) or placebo (once daily)"
        },
        "conditionsModule": {
            "conditions": [
                "Hereditary Hemorrhagic Telangiectasia (HHT)"
            ],
            "keywords": [
                "Osler-Weber-Rendu disease",
                "Arteriovenous Malformations"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE1"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "PARALLEL",
                "interventionModelDescription": "The patients will be randomised into VAD044 30 mg or 40 mg or placebo group in the ratio 1:1:1, according to a centralised randomisation process",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 80,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "30 mg",
                    "type": "EXPERIMENTAL",
                    "description": "30 mg VAD044",
                    "interventionNames": [
                        "Drug: VAD044"
                    ]
                },
                {
                    "label": "40 mg",
                    "type": "EXPERIMENTAL",
                    "description": "40 mg VAD044",
                    "interventionNames": [
                        "Drug: VAD044"
                    ]
                },
                {
                    "label": "Placebo",
                    "type": "PLACEBO_COMPARATOR",
                    "description": "Placebo",
                    "interventionNames": [
                        "Drug: VAD044"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "VAD044",
                    "description": "capsules to be taken once daily for 12 weeks",
                    "armGroupLabels": [
                        "30 mg",
                        "40 mg",
                        "Placebo"
                    ],
                    "otherNames": [
                        "VAD044 L-Tartrate gelatin capsules"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Safety and Tolerability",
                    "description": "Type and severity of Adverse Events (AEs)",
                    "timeFrame": "12 weeks"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Change in Epistaxis Frequency",
                    "description": "The number of Epistaxis episodes over four weeks",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Pharmacokinetics (PK) of VAD044",
                    "description": "Plasma concentration of VAD044",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Change in the Nasal Outcome for Epistaxis in Hereditary Hemorrhagic Telangiectasia score",
                    "description": "The Nasal Outcome for Epistaxis in Hereditary Hemorrhagic Telangiectasia (NOSE HHT questionnaire) wil be used to measure physical, social and emotional impacts of epistaxis. It is a 29-items questionnaire using a Likert scale. A higher score indicates a worse outcome",
                    "timeFrame": "12 weeks"
                },
                {
                    "measure": "Quality of Life Scale SF-12",
                    "description": "The SF-12 Quality of Life Scale is a scale to evaluate quality of life using 12 questions. In the SF-12, physical (SF12-PCS) and mental (SF12-MCS) component summary scores are calculated as sub-dimensions. The total score of the physical and mental component summary of the scale varies between 0-100. An increase in the score indicates well-being, and a decrease indicates a state of disability.",
                    "timeFrame": "12 weeks"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* diagnosis of HHT by the Cura\u00e7ao criteria\n* several epistaxis/week\n* anaemia\n* COVID-19 vaccination or positive COVID-19 antibody test\n\nExclusion Criteria:\n\n* Type 1 diabetes or uncontrolled type II diabetes (insulin or non-insulin dependent)\n* Active COVID-19 infection\n* active uncontrolled infection or known to be serologically positive for HIV, Hep B, Hep C infection\n* Recent procedures on nasal telangiectases (\\<6 weeks)\n* Requiring therapeutic anticoagulation\n* Use of drugs with anti-angiogenic properties in the past 8 weeks\n* laboratory abnormalities",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Hedvika Lazar",
                    "role": "CONTACT",
                    "phone": "+41763217280",
                    "email": "hlazar@vaderis.com"
                },
                {
                    "name": "Damien Picard",
                    "role": "CONTACT",
                    "email": "dpicard@vaderis.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Damien Picard",
                    "affiliation": "Vaderis Therapeutics AG",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Massachusetts General Hospital",
                    "status": "RECRUITING",
                    "city": "Boston",
                    "state": "Massachusetts",
                    "zip": "02114",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.35843,
                        "lon": -71.05977
                    }
                },
                {
                    "facility": "Washington University School of Medicine",
                    "status": "RECRUITING",
                    "city": "Saint Louis",
                    "state": "Missouri",
                    "zip": "63110",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 38.62727,
                        "lon": -90.19789
                    }
                },
                {
                    "facility": "Universitair Ziekenhuis Gent",
                    "status": "RECRUITING",
                    "city": "Gent",
                    "country": "Belgium",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 51.05,
                        "lon": 3.71667
                    }
                },
                {
                    "facility": "Hospices Civils de Lyon",
                    "status": "RECRUITING",
                    "city": "Lyon",
                    "country": "France",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.74848,
                        "lon": 4.84669
                    }
                },
                {
                    "facility": "Ospedale Maggiore di Crema",
                    "status": "RECRUITING",
                    "city": "Crema",
                    "country": "Italy",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 45.36264,
                        "lon": 9.68176
                    }
                },
                {
                    "facility": "St. Antonius Hospital",
                    "status": "RECRUITING",
                    "city": "Nieuwegein",
                    "country": "Netherlands",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 52.02917,
                        "lon": 5.08056
                    }
                },
                {
                    "facility": "Hospital Universiati De Bellvitge",
                    "status": "RECRUITING",
                    "city": "Barcelona",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "email": "hlazar@vaderis.com"
                        }
                    ],
                    "geoPoint": {
                        "lat": 41.38879,
                        "lon": 2.15899
                    }
                },
                {
                    "facility": "Hospital Universitario Ram\u00f3n y Cajal",
                    "status": "RECRUITING",
                    "city": "Madrid",
                    "country": "Spain",
                    "contacts": [
                        {
                            "name": "Hedvika Lazar",
                            "role": "CONTACT",
                            "phone": "+41763217280",
                            "email": "hlazar@vaderis.com"
                        },
                        {
                            "name": "Viteri",
                            "role": "CONTACT"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.4165,
                        "lon": -3.70256
                    }
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30",
            "removedCountries": [
                "Canada"
            ]
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000013684",
                    "term": "Telangiectasis"
                },
                {
                    "id": "D000013683",
                    "term": "Telangiectasia, Hereditary Hemorrhagic"
                }
            ],
            "ancestors": [
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000020141",
                    "term": "Hemostatic Disorders"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000054079",
                    "term": "Vascular Malformations"
                },
                {
                    "id": "D000018376",
                    "term": "Cardiovascular Abnormalities"
                },
                {
                    "id": "D000000013",
                    "term": "Congenital Abnormalities"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12",
                    "name": "Congenital Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "M4473",
                    "name": "Arteriovenous Malformations",
                    "relevance": "LOW"
                },
                {
                    "id": "M16456",
                    "name": "Telangiectasis",
                    "asFound": "Telangiectasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M16455",
                    "name": "Telangiectasia, Hereditary Hemorrhagic",
                    "asFound": "Hereditary Hemorrhagic Telangiectasia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M27558",
                    "name": "Vascular Malformations",
                    "relevance": "LOW"
                },
                {
                    "id": "M20503",
                    "name": "Cardiovascular Abnormalities",
                    "relevance": "LOW"
                },
                {
                    "id": "T2750",
                    "name": "Hereditary Hemorrhagic Telangiectasia",
                    "asFound": "Hereditary Hemorrhagic Telangiectasia",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}